Kenya Airways (KQ) has unveiled a state-of-the-art pharma facility at Jomo Kenyatta International Airport (JKIA) through its cargo arm KQ Cargo to help meet demand for medical shipments around the world.
According to Dick Murianki, KQ Cargo Manager, the immediate aim of the facility would be to boost logistics for the delivery of a possible COVID-19 vaccine in Africa.
Mr. Murianki says “KQ Cargo has worked closely with pharmaceutical and medical customers to ensure that they are able to safely and effectively meet their vaccine transport needs to travel efficiently once the vaccine has been licenced by the regulators.”
“Although coinciding with the COVID-19 pandemic, investment in the pharmaceutical facility will help meet the global demand for pharmaceutical products in preparation for the big task of transporting medications, vaccines, blood samples and temperature-sensitive cargo by providing an end-to-end cold chain logistics solution,” he added.
Since March of this year the national carrier has been transporting essential goods and medical supplies, some 6,000 tonnes of much-needed medical equipment to help tackle the COVID-19 pandemic.
Jomo Kenyatta International Airport (JKIA) in Nairobi was a distribution and logistics hub in Africa and was ranked by ACI as the second fastest-growing cargo airport in the world in 2019.
KQ has also joined forces with global leaders in cold chain technologies to deliver active and passive packaging with dedicated equipment for streamlined cold chain operations.